| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.915 | 0.004 | 0.943 | Analgesic | 0.943 0.004 CID_130829 0.886 0.005 CID_198555 | CID_130829 | |
| 0.652 | 0.009 | 0.67 | Spasmolytic | 0.67 0.008 CID_130829 0.603 0.013 CID_198555 | CID_130829 | |
| 0.598 | 0.004 | 0.611 | Sigma receptor agonist | 0.611 0.004 CID_130829 0.303 0.038 CID_198555 | CID_130829 | |
| 0.56 | 0.024 | 0.58 | Cholesterol antagonist | 0.58 0.021 CID_130829 0.495 0.033 CID_198555 | CID_130829 | |
| 0.531 | 0.004 | 0.65 | Analgesic, opioid | 0.65 0.003 CID_130829 0.42 0.004 CID_198555 | CID_130829 | |
| 0.51 | 0.004 | 0.553 | 5 Hydroxytryptamine uptake inhibitor | 0.553 0.004 CID_130829 0.519 0.004 CID_198555 | CID_130829 | |
| 0.492 | 0.004 | 0.639 | Opioid antagonist | 0.639 0.003 CID_130829 0.421 0.004 CID_198555 | CID_130829 | |
| 0.48 | 0.005 | 0.543 | Antipruritic | 0.543 0.004 CID_130829 0.341 0.01 CID_198555 | CID_130829 | |
| 0.453 | 0.004 | 0.512 | Adrenaline uptake inhibitor | 0.512 0.003 CID_130829 0.474 0.003 CID_198555 | CID_130829 | |
| 0.44 | 0.004 | 0.604 | Opioid agonist | 0.604 0.003 CID_130829 0.296 0.004 CID_198555 | CID_130829 | |
| 0.413 | 0.004 | 0.475 | Opioid kappa receptor antagonist | 0.475 0.003 CID_130829 0.393 0.004 CID_198555 | CID_130829 | |
| 0.411 | 0.025 | 0.522 | Potassium channel (Voltage-sensitive) blocker | 0.394 0.028 CID_130829 0.522 0.013 CID_198555 | CID_198555 | |
| 0.39 | 0.004 | 0.558 | Opioid mu receptor antagonist | 0.558 0.003 CID_130829 0.321 0.005 CID_198555 | CID_130829 | |
| 0.448 | 0.084 | 0.465 | Caspase 9 stimulant | 0.392 0.116 CID_130829 0.465 0.075 CID_198555 | CID_198555 | |
| 0.392 | 0.029 | 0.512 | HERG channel blocker | 0.399 0.028 CID_130829 0.512 0.014 CID_198555 | CID_198555 | |
| 0.349 | 0.004 | 0.539 | Opioid mu receptor agonist | 0.539 0.003 CID_130829 0.261 0.004 CID_198555 | CID_130829 | |
| 0.374 | 0.034 | 0.374 | Antiamyloidogenic | 0.355 0.038 CID_130829 0.261 0.066 CID_198555 | ||
| 0.355 | 0.025 | 0.355 | Cyclic AMP phosphodiesterase inhibitor | 0.349 0.026 CID_130829 0.162 0.133 CID_198555 | ||
| 0.332 | 0.037 | 0.391 | Potassium channel blocker | 0.3 0.046 CID_130829 0.391 0.024 CID_198555 | CID_198555 | |
| 0.27 | 0.003 | 0.301 | Opioid kappa receptor agonist | 0.301 0.003 CID_130829 0.237 0.004 CID_198555 | CID_130829 | |
| 0.262 | 0.005 | 0.274 | Dopamine uptake inhibitor | 0.274 0.004 CID_130829 0.213 0.005 CID_198555 | CID_130829 | |
| 0.31 | 0.089 | 0.342 | Transcription factor NF kappa B inhibitor | 0.342 0.079 CID_130829 0.289 0.101 CID_198555 | CID_130829 | |
| 0.283 | 0.088 | 0.283 | Caspase 3 stimulant | 0.253 0.109 CID_130829 0.233 0.128 CID_198555 | ||
| 0.219 | 0.027 | 0.219 | Anesthetic local | 0.213 0.029 CID_130829 0.1 0.083 CID_198555 | ||
| 0.26 | 0.071 | 0.283 | 5 Hydroxytryptamine uptake stimulant | 0.283 0.054 CID_130829 0.265 0.067 CID_198555 | CID_130829 | |
| 0.2 | 0.014 | 0.21 | Antineoplastic alkaloid | 0.21 0.011 CID_130829 0.136 0.032 CID_198555 | CID_130829 | |
| 0.24 | 0.055 | 0.25 | Anesthetic general | 0.25 0.05 CID_130829 0.206 0.071 CID_198555 | CID_130829 | |
| 0.208 | 0.026 | 0.214 | Arachidonic acid antagonist | 0.214 0.021 CID_130829 0.15 0.088 CID_198555 | CID_130829 | |
| 0.238 | 0.063 | 0.257 | Psychostimulant | 0.253 0.057 CID_130829 0.257 0.056 CID_198555 | CID_198555 | |
| 0.175 | 0.004 | 0.372 | Opioid delta receptor agonist | 0.372 0.004 CID_130829 0.092 0.005 CID_198555 | CID_130829 | |
| 0.273 | 0.105 | 0.301 | Sodium/bile acid cotransporter inhibitor | 0.301 0.078 CID_130829 0.288 0.091 CID_198555 | CID_130829 | |
| 0.181 | 0.014 | 0.268 | Opioid delta receptor antagonist | 0.268 0.005 CID_130829 0.158 0.018 CID_198555 | CID_130829 | |
| 0.17 | 0.013 | 0.222 | Dopamine D1 antagonist | 0.222 0.009 CID_130829 0.121 0.02 CID_198555 | CID_130829 | |
| 0.269 | 0.116 | 0.269 | Vasodilator, coronary | 0.225 0.159 CID_130829 | ||
| 0.193 | 0.044 | 0.196 | Melanin inhibitor | 0.196 0.042 CID_130829 0.148 0.084 CID_198555 | CID_130829 | |
| 0.186 | 0.037 | 0.189 | 5 Hydroxytryptamine antagonist | 0.142 0.053 CID_130829 0.189 0.036 CID_198555 | CID_198555 | |
| 0.271 | 0.123 | 0.356 | Calcium channel activator | 0.218 0.188 CID_130829 0.356 0.046 CID_198555 | CID_198555 | |
| 0.16 | 0.016 | 0.165 | Toll-Like receptor 4 antagonist | 0.165 0.014 CID_130829 0.148 0.022 CID_198555 | CID_130829 | |
| 0.163 | 0.02 | 0.163 | Alpha 2a adrenoreceptor antagonist | 0.154 0.021 CID_130829 0.149 0.022 CID_198555 | ||
| 0.207 | 0.066 | 0.207 | Non-steroidal antiinflammatory agent | 0.187 0.082 CID_130829 | ||
| 0.187 | 0.051 | 0.187 | MAP kinase kinase 5 inhibitor | 0.17 0.086 CID_130829 | ||
| 0.16 | 0.025 | 0.16 | Alpha 2 adrenoreceptor antagonist | 0.139 0.03 CID_130829 0.139 0.03 CID_198555 | ||
| 0.224 | 0.093 | 0.293 | Aldehyde oxidase inhibitor | 0.293 0.068 CID_130829 | CID_130829 | |
| 0.155 | 0.03 | 0.159 | Alpha 2c adrenoreceptor antagonist | 0.139 0.038 CID_130829 0.159 0.028 CID_198555 | CID_198555 | |
| 0.127 | 0.008 | 0.141 | Dopamine transporter inhibitor | 0.141 0.007 CID_130829 0.126 0.008 CID_198555 | CID_130829 | |
| 0.164 | 0.047 | 0.164 | Acetylcholinesterase inhibitor | 0.143 0.06 CID_130829 0.117 0.081 CID_198555 | ||
| 0.187 | 0.074 | 0.187 | P-glycoprotein inhibitor | 0.155 0.11 CID_130829 0.156 0.107 CID_198555 | ||
| 0.15 | 0.038 | 0.202 | Alpha 2b adrenoreceptor antagonist | 0.135 0.047 CID_130829 0.202 0.023 CID_198555 | CID_198555 | |
| 0.203 | 0.096 | 0.23 | RNA-directed DNA polymerase inhibitor | 0.23 0.064 CID_130829 0.182 0.13 CID_198555 | CID_130829 | |
| 0.217 | 0.111 | 0.242 | 5 Hydroxytryptamine 1E antagonist | 0.224 0.104 CID_130829 0.242 0.083 CID_198555 | CID_198555 | |
| 0.179 | 0.077 | 0.195 | Nitric oxide antagonist | 0.195 0.069 CID_130829 0.171 0.081 CID_198555 | CID_130829 | |
| 0.175 | 0.076 | 0.177 | Lipocortins synthesis antagonist | 0.177 0.073 CID_130829 0.162 0.089 CID_198555 | CID_130829 | |
| 0.15 | 0.053 | 0.162 | Pregnane X receptor agonist | 0.162 0.035 CID_130829 0.138 0.078 CID_198555 | CID_130829 | |
| 0.206 | 0.109 | 0.246 | Neuropeptide Y2 antagonist | 0.246 0.06 CID_130829 | CID_130829 | |
| 0.142 | 0.047 | 0.176 | Vanilloid 1 agonist | 0.135 0.057 CID_130829 0.176 0.02 CID_198555 | CID_198555 | |
| 0.17 | 0.076 | 0.17 | Tumour necrosis factor antagonist | 0.158 0.091 CID_198555 | ||
| 0.152 | 0.059 | 0.18 | Adenylate cyclase stimulant | 0.178 0.028 CID_130829 0.18 0.025 CID_198555 | CID_198555 | |
| 0.167 | 0.075 | 0.171 | ATPase inhibitor | 0.171 0.07 CID_130829 0.143 0.114 CID_198555 | CID_130829 | |
| 0.126 | 0.034 | 0.183 | Prolactin inhibitor | 0.183 0.012 CID_130829 0.12 0.038 CID_198555 | CID_130829 | |
| 0.094 | 0.005 | 0.094 | Ryanodine receptor antagonist | 0.07 0.017 CID_130829 0.087 0.005 CID_198555 | ||
| 0.139 | 0.051 | 0.175 | Acetylcholine muscarinic antagonist | 0.175 0.032 CID_130829 0.11 0.079 CID_198555 | CID_130829 | |
| 0.138 | 0.052 | 0.146 | Cholesterol synthesis inhibitor | 0.146 0.047 CID_130829 | CID_130829 | |
| 0.202 | 0.117 | 0.202 | Cardiotonic | 0.185 0.134 CID_130829 0.182 0.137 CID_198555 | ||
| 0.217 | 0.132 | 0.217 | Hypoxia-inducible factor 1 alpha inhibitor | 0.202 0.149 CID_130829 | ||
| 0.133 | 0.049 | 0.133 | Microtubule formation inhibitor | 0.115 0.067 CID_130829 0.118 0.063 CID_198555 | ||
| 0.127 | 0.044 | 0.146 | Nav1.1 sodium channel blocker | 0.146 0.035 CID_130829 0.117 0.05 CID_198555 | CID_130829 | |
| 0.154 | 0.071 | 0.197 | Acetylcholine M1 receptor antagonist | 0.197 0.044 CID_130829 0.15 0.074 CID_198555 | CID_130829 | |
| 0.153 | 0.071 | 0.161 | CF transmembrane conductance regulator agonist | 0.161 0.058 CID_130829 0.136 0.105 CID_198555 | CID_130829 | |
| 0.153 | 0.074 | 0.153 | Cholinergic | 0.133 0.092 CID_130829 | ||
| 0.197 | 0.122 | 0.274 | Immunostimulant | 0.274 0.087 CID_130829 0.154 0.152 CID_198555 | CID_130829 | |
| 0.084 | 0.012 | 0.084 | Calcium channel P-type blocker | |||
| 0.202 | 0.131 | 0.267 | Tyrosine 3 hydroxylase inhibitor | 0.267 0.053 CID_130829 0.209 0.12 CID_198555 | CID_130829 | |
| 0.164 | 0.095 | 0.173 | Hepatoprotectant | 0.173 0.087 CID_130829 0.158 0.102 CID_198555 | CID_130829 | |
| 0.117 | 0.049 | 0.117 | Butyrylcholinesterase inhibitor | 0.104 0.059 CID_130829 | ||
| 0.099 | 0.032 | 0.11 | Na+ K+ transporting ATPase inhibitor | 0.11 0.023 CID_130829 0.082 0.048 CID_198555 | CID_130829 | |
| 0.134 | 0.073 | 0.134 | Calcium channel blocker | |||
| 0.134 | 0.075 | 0.134 | Nav1.6 sodium channel blocker | 0.128 0.084 CID_130829 0.13 0.081 CID_198555 | ||
| 0.073 | 0.016 | 0.08 | 5 Hydroxytryptamine 4 antagonist | 0.059 0.025 CID_130829 0.08 0.013 CID_198555 | CID_198555 | |
| 0.108 | 0.052 | 0.138 | Anabolic | 0.138 0.025 CID_130829 0.103 0.059 CID_198555 | CID_130829 | |
| 0.063 | 0.009 | 0.068 | GABA uptake inhibitor | 0.068 0.007 CID_130829 0.044 0.021 CID_198555 | CID_130829 | |
| 0.072 | 0.02 | 0.072 | Glycine transporter inhibitor | 0.067 0.022 CID_130829 0.062 0.024 CID_198555 | ||
| 0.213 | 0.161 | 0.379 | Vasodilator, peripheral | 0.379 0.062 CID_198555 | CID_198555 | |
| 0.166 | 0.114 | 0.172 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.172 0.104 CID_130829 | CID_130829 | |
| 0.066 | 0.015 | 0.066 | Alpha 1L adrenoreceptor antagonist | 0.049 0.047 CID_130829 | ||
| 0.085 | 0.035 | 0.085 | Calcium channel L-type blocker | |||
| 0.09 | 0.041 | 0.1 | Estrogen-related receptor beta agonist | 0.1 0.024 CID_130829 0.08 0.068 CID_198555 | CID_130829 | |
| 0.055 | 0.009 | 0.071 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.071 0.006 CID_130829 | CID_130829 | |
| 0.129 | 0.084 | 0.137 | Protein kinase stimulant | 0.137 0.078 CID_130829 0.131 0.083 CID_198555 | CID_130829 | |
| 0.119 | 0.074 | 0.153 | Cholinergic antagonist | 0.153 0.051 CID_130829 | CID_130829 | |
| 0.081 | 0.039 | 0.081 | Dopamine D2 antagonist | 0.073 0.042 CID_130829 0.064 0.047 CID_198555 | ||
| 0.116 | 0.074 | 0.148 | Acetylcholine antagonist | 0.148 0.051 CID_130829 | CID_130829 | |
| 0.1 | 0.059 | 0.122 | Sphingomyelinase inhibitor | 0.122 0.04 CID_198555 | CID_198555 | |
| 0.071 | 0.03 | 0.071 | 5 Hydroxytryptamine 5A antagonist | 0.068 0.033 CID_130829 0.07 0.031 CID_198555 | ||
| 0.119 | 0.078 | 0.119 | Cyclooxygenase 3 inhibitor | 0.113 0.086 CID_130829 0.117 0.081 CID_198555 | ||
| 0.048 | 0.013 | 0.056 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.056 0.009 CID_130829 | CID_130829 | |
| 0.049 | 0.015 | 0.068 | Nociceptin (N/OFQ) receptor antagonist | 0.068 0.009 CID_130829 0.036 0.024 CID_198555 | CID_130829 | |
| 0.08 | 0.046 | 0.089 | Alpha 1b adrenoreceptor antagonist | 0.089 0.04 CID_198555 | CID_198555 | |
| 0.064 | 0.031 | 0.065 | 5 Hydroxytryptamine 5 antagonist | 0.059 0.039 CID_130829 0.065 0.03 CID_198555 | CID_198555 | |
| 0.055 | 0.022 | 0.086 | Estradiol 17 beta-dehydrogenase inhibitor | 0.086 0.012 CID_130829 | CID_130829 | |
| 0.094 | 0.061 | 0.094 | Alpha adrenoreceptor antagonist | 0.078 0.074 CID_198555 | ||
| 0.074 | 0.041 | 0.076 | Leukotriene synthesis inhibitor | 0.076 0.04 CID_130829 0.065 0.049 CID_198555 | CID_130829 | |
| 0.133 | 0.102 | 0.142 | Ca2+-transporting ATPase inhibitor | 0.142 0.064 CID_130829 | CID_130829 | |
| 0.176 | 0.145 | 0.259 | 5 Hydroxytryptamine release stimulant | 0.198 0.123 CID_130829 0.259 0.085 CID_198555 | CID_198555 | |
| 0.088 | 0.057 | 0.088 | Calcium antagonist | |||
| 0.036 | 0.006 | 0.036 | Hedgehog signaling activator | 0.03 0.013 CID_130829 0.031 0.011 CID_198555 | ||
| 0.074 | 0.044 | 0.074 | 5 Hydroxytryptamine 1A antagonist | 0.058 0.055 CID_198555 | ||
| 0.078 | 0.049 | 0.078 | Dopamine antagonist | 0.073 0.052 CID_130829 0.064 0.06 CID_198555 | ||
| 0.271 | 0.244 | 0.339 | Antiinflammatory | 0.339 0.181 CID_130829 | CID_130829 | |
| 0.17 | 0.143 | 0.219 | Antioxidant | 0.219 0.102 CID_130829 | CID_130829 | |
| 0.076 | 0.049 | 0.076 | 5 Hydroxytryptamine 1 antagonist | 0.069 0.055 CID_198555 | ||
| 0.052 | 0.027 | 0.052 | Potassium channel Kv1.3 blocker | |||
| 0.083 | 0.058 | 0.091 | Histamine H2 receptor antagonist | 0.081 0.062 CID_130829 0.091 0.045 CID_198555 | CID_198555 | |
| 0.058 | 0.035 | 0.058 | Pregnane X receptor antagonist | 0.055 0.045 CID_130829 | ||
| 0.243 | 0.222 | 0.243 | Apoptosis agonist | 0.235 0.231 CID_198555 | ||
| 0.102 | 0.082 | 0.102 | Acetylcholine release stimulant | |||
| 0.13 | 0.11 | 0.141 | Interferon gamma antagonist | 0.141 0.09 CID_130829 0.13 0.11 CID_198555 | CID_130829 | |
| 0.138 | 0.118 | 0.147 | Amyloid beta aggregation inhibitor | 0.147 0.11 CID_130829 | CID_130829 | |
| 0.101 | 0.081 | 0.101 | Electron transport complex I inhibitor | |||
| 0.08 | 0.063 | 0.111 | CC chemokine 5 receptor agonist | 0.111 0.012 CID_130829 0.086 0.046 CID_198555 | CID_130829 | |
| 0.135 | 0.12 | 0.136 | Amyloid beta precursor protein antagonist | 0.136 0.119 CID_130829 | CID_130829 | |
| 0.206 | 0.191 | 0.212 | Immunosuppressant | 0.212 0.185 CID_130829 | CID_130829 | |
| 0.197 | 0.183 | 0.219 | Apoptosis antagonist | 0.219 0.158 CID_130829 0.195 0.186 CID_198555 | CID_130829 | |
| 0.179 | 0.165 | 0.179 | Lipoxygenase inhibitor | 0.179 0.165 CID_130829 | ||
| 0.103 | 0.09 | 0.146 | Estrogen antagonist | 0.146 0.025 CID_130829 | CID_130829 | |
| 0.034 | 0.022 | 0.063 | Melatonin receptor 1A agonist | 0.063 0.005 CID_198555 | CID_198555 | |
| 0.017 | 0.006 | 0.02 | Antibiotic Tetracycline-like | 0.02 0.004 CID_130829 0.015 0.013 CID_198555 | CID_130829 | |
| 0.086 | 0.075 | 0.103 | 5-Lipoxygenase inhibitor | 0.103 0.062 CID_130829 | CID_130829 | |
| 0.056 | 0.046 | 0.084 | Acetylcholine M3 receptor antagonist | 0.084 0.024 CID_130829 | CID_130829 | |
| 0.073 | 0.064 | 0.073 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.09 | 0.081 | 0.092 | Expectorant | 0.092 0.078 CID_198555 | CID_198555 | |
| 0.089 | 0.081 | 0.089 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.045 | 0.038 | 0.058 | Sigma receptor antagonist | 0.058 0.029 CID_130829 | CID_130829 | |
| 0.043 | 0.037 | 0.058 | Adenylate cyclase 1 inhibitor | 0.045 0.033 CID_130829 0.058 0.019 CID_198555 | CID_198555 | |
| 0.071 | 0.066 | 0.093 | Estrogen receptor alpha antagonist | 0.093 0.032 CID_130829 | CID_130829 | |
| 0.046 | 0.041 | 0.069 | Topoisomerase II beta inhibitor | 0.069 0.017 CID_130829 | CID_130829 | |
| 0.02 | 0.016 | 0.027 | Nociceptin (N/OFQ) receptor agonist | 0.027 0.011 CID_130829 0.02 0.015 CID_198555 | CID_130829 | |
| 0.059 | 0.058 | 0.063 | Beta 3 adrenoreceptor antagonist | 0.063 0.046 CID_130829 0.059 0.057 CID_198555 | CID_130829 | |
| 0.014 | 0.013 | 0.02 | NMDA receptor phencyclidine site antagonist | 0.019 0.008 CID_130829 0.02 0.007 CID_198555 | CID_198555 | |
| 0.039 | 0.038 | 0.046 | Nerve growth factor antagonist | 0.046 0.024 CID_130829 | CID_130829 | |
| 0.078 | 0.077 | 0.104 | Vanilloid agonist | 0.08 0.07 CID_130829 0.104 0.029 CID_198555 | CID_198555 | |
| 0.045 | 0.045 | 0.052 | Squalene epoxidase inhibitor | 0.052 0.031 CID_130829 | CID_130829 | |
| 0.031 | 0.032 | 0.037 | Protein kinase C beta I inhibitor | 0.037 0.013 CID_130829 | CID_130829 | |
| 0.05 | 0.054 | 0.065 | Acetylcholine M2 receptor antagonist | 0.065 0.04 CID_130829 | CID_130829 | |
| 0.09 | 0.094 | 0.141 | Adenylate cyclase inhibitor | 0.141 0.051 CID_130829 0.125 0.063 CID_198555 | CID_130829 | |
| 0.086 | 0.092 | 0.129 | Estrogen receptor beta antagonist | 0.129 0.024 CID_130829 | CID_130829 | |
| 0.12 | 0.126 | 0.128 | Sphingosine 1-phosphate receptor 5 antagonist | 0.128 0.104 CID_130829 | CID_130829 | |
| 0.019 | 0.026 | 0.022 | Protein 30S ribosomal subunit inhibitor | 0.022 0.019 CID_130829 0.022 0.019 CID_198555 | CID_198555 | |
| 0.142 | 0.151 | 0.198 | Neurotrophic factor enhancer | 0.198 0.078 CID_130829 0.163 0.119 CID_198555 | CID_130829 | |
| 0.125 | 0.136 | 0.14 | Interleukin 6 antagonist | 0.129 0.127 CID_130829 0.14 0.106 CID_198555 | CID_198555 | |
| 0.078 | 0.091 | 0.111 | Chemokine receptor antagonist | 0.111 0.054 CID_130829 | CID_130829 | |
| 0.073 | 0.087 | 0.082 | Ca(v)3.1 blocker | 0.08 0.062 CID_130829 0.082 0.055 CID_198555 | CID_198555 | |
| 0.11 | 0.125 | 0.116 | Sphingosine 1-phosphate receptor 2 antagonist | 0.116 0.107 CID_130829 0.115 0.109 CID_198555 | CID_130829 | |
| 0.067 | 0.082 | 0.082 | Glycine receptor antagonist | 0.082 0.054 CID_130829 | CID_130829 | |
| 0.034 | 0.05 | 0.094 | Estrogen agonist | 0.094 0.019 CID_130829 | CID_130829 | |
| 0.1 | 0.117 | 0.136 | Lipid peroxidase inhibitor | 0.136 0.079 CID_130829 | CID_130829 | |
| 0.02 | 0.037 | 0.024 | 5 Hydroxytryptamine 4 agonist | 0.024 0.018 CID_198555 | CID_198555 | |
| 0.017 | 0.037 | 0.079 | Estrogen receptor alpha agonist | 0.079 0.012 CID_130829 | CID_130829 | |
| 0.026 | 0.048 | 0.035 | Protein kinase C beta II inhibitor | 0.035 0.018 CID_130829 | CID_130829 | |
| 0.158 | 0.181 | 0.176 | 5 Hydroxytryptamine 3E antagonist | 0.176 0.118 CID_130829 | CID_130829 | |
| 0.105 | 0.13 | 0.175 | Papain-like protease (SARS coronavirus) inhibitor | 0.127 0.066 CID_130829 0.175 0.018 CID_198555 | CID_198555 | |
| 0.028 | 0.053 | 0.037 | Delayed rectifier potassium channel blocker | 0.037 0.027 CID_198555 | CID_198555 | |
| 0.007 | 0.032 | 0.012 | Melatonin 2 antagonist | 0.012 0.009 CID_198555 | CID_198555 | |
| 0.037 | 0.065 | 0.055 | Alpha 1d adrenoreceptor antagonist | 0.055 0.044 CID_198555 | CID_198555 | |
| 0.067 | 0.096 | 0.092 | MAP kinase kinase 7 inhibitor | 0.092 0.022 CID_130829 | CID_130829 | |
| 0.081 | 0.112 | 0.119 | Glutamate (mGluR7) agonist | 0.119 0.031 CID_198555 | CID_198555 | |
| 0.04 | 0.07 | 0.08 | NMDA 2B receptor antagonist | 0.08 0.021 CID_130829 | CID_130829 | |
| 0.124 | 0.156 | 0.13 | Heat shock protein 70 antagonist | 0.13 0.123 CID_130829 | CID_130829 | |
| 0.086 | 0.12 | 0.101 | TRPA1 agonist | 0.101 0.086 CID_130829 | CID_130829 | |
| 0.073 | 0.109 | 0.1 | Lanosterol 14 alpha demethylase inhibitor | 0.1 0.056 CID_130829 | CID_130829 | |
| 0.01 | 0.047 | 0.086 | Estrogen receptor beta agonist | 0.086 0.013 CID_130829 | CID_130829 | |
| 0.071 | 0.112 | 0.12 | GABA C receptor agonist | 0.12 0.05 CID_130829 | CID_130829 | |
| 0.023 | 0.066 | 0.035 | Estrogen-related receptor beta antagonist | 0.035 0.018 CID_130829 | CID_130829 | |
| 0.038 | 0.082 | 0.079 | 5 Hydroxytryptamine 2A agonist | 0.079 0.028 CID_198555 | CID_198555 | |
| 0.048 | 0.092 | 0.08 | Protein kinase C beta inhibitor | 0.08 0.03 CID_130829 | CID_130829 | |
| 0.131 | 0.175 | 0.169 | Free radical scavenger | 0.169 0.125 CID_130829 | CID_130829 | |
| 0.019 | 0.064 | 0.035 | Melatonin 2 agonist | 0.035 0.02 CID_198555 | CID_198555 | |
| 0.073 | 0.119 | 0.094 | Cystathionine beta-synthase inhibitor | 0.094 0.084 CID_130829 | CID_130829 | |
| 0.019 | 0.065 | 0.041 | Melatonin agonist | 0.041 0.014 CID_198555 | CID_198555 | |
| 0.019 | 0.069 | 0.043 | Melatonin 1 agonist | 0.043 0.013 CID_198555 | CID_198555 | |
| 0.03 | 0.084 | 0.052 | 5 Hydroxytryptamine 2 agonist | 0.052 0.036 CID_198555 | CID_198555 | |
| 0.019 | 0.075 | 0.044 | NMDA receptor subunit 3A antagonist | 0.044 0.023 CID_130829 | CID_130829 | |
| 0.206 | 0.264 | 0.372 | Calcium channel L-type activator | 0.288 0.168 CID_130829 0.372 0.101 CID_198555 | CID_198555 | |
| 0.022 | 0.08 | 0.05 | Dopamine D5 agonist | 0.05 0.017 CID_130829 | CID_130829 | |
| 0.008 | 0.07 | 0.019 | Melatonin 1 antagonist | 0.019 0.013 CID_198555 | CID_198555 | |
| 0.035 | 0.102 | 0.107 | NMDA 2 receptor antagonist | 0.107 0.028 CID_130829 0.066 0.055 CID_198555 | CID_130829 | |
| 0.071 | 0.139 | 0.114 | GABA C receptor antagonist | 0.114 0.059 CID_130829 | CID_130829 | |
| 0.145 | 0.214 | 0.185 | DNA synthesis inhibitor | 0.185 0.147 CID_130829 0.176 0.16 CID_198555 | CID_130829 | |
| 0.023 | 0.093 | 0.033 | Antibiotic Aminoglycoside-like | 0.033 0.031 CID_198555 | CID_198555 | |
| 0.01 | 0.083 | 0.03 | Melatonin antagonist | 0.03 0.017 CID_198555 | CID_198555 | |
| 0.009 | 0.084 | 0.032 | Arginase inhibitor | 0.032 0.029 CID_130829 | CID_130829 | |
| 0.022 | 0.098 | 0.04 | NMDA receptor subunit 3B antagonist | 0.04 0.035 CID_130829 | CID_130829 | |
| 0.047 | 0.135 | 0.088 | Histamine N-methyltransferase inhibitor | 0.088 0.058 CID_130829 | CID_130829 | |
| 0.139 | 0.228 | 0.175 | Peptidyltransferase inhibitor | 0.175 0.138 CID_130829 0.169 0.149 CID_198555 | CID_130829 | |
| 0.071 | 0.163 | 0.107 | DOPA decarboxylase inhibitor | 0.107 0.062 CID_130829 | CID_130829 | |
| 0.172 | 0.264 | 0.208 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.208 0.144 CID_198555 | CID_198555 | |
| 0.032 | 0.128 | 0.057 | Fatty acid synthase inhibitor | 0.057 0.04 CID_130829 | CID_130829 | |
| 0.017 | 0.112 | 0.051 | NMDA 2A receptor antagonist | 0.051 0.037 CID_130829 | CID_130829 | |
| 0.022 | 0.125 | 0.036 | 5 Hydroxytryptamine 2B agonist | 0.036 0.035 CID_198555 | CID_198555 | |
| 0.108 | 0.225 | 0.141 | Phospholipase C inhibitor | 0.141 0.126 CID_130829 | CID_130829 | |
| 0.038 | 0.162 | 0.087 | NMDA receptor antagonist | 0.087 0.057 CID_130829 | CID_130829 | |
| 0.023 | 0.153 | 0.059 | H+/K+-transporting ATPase inhibitor | 0.059 0.026 CID_198555 | CID_198555 | |
| 0.136 | 0.287 | 0.193 | Insulysin inhibitor | 0.193 0.167 CID_130829 | CID_130829 | |
| 0.12 | 0.274 | 0.199 | Gastrin inhibitor | 0.199 0.15 CID_198555 | CID_198555 | |
| 0.017 | 0.173 | 0.11 | 5 Hydroxytryptamine agonist | 0.11 0.031 CID_198555 | CID_198555 | |
| 0.065 | 0.226 | 0.115 | Peroxidase inhibitor | 0.115 0.106 CID_130829 | CID_130829 | |
| 0.04 | 0.217 | 0.112 | Creatine kinase inhibitor | 0.112 0.047 CID_130829 | CID_130829 | |
| 0.104 | 0.406 | 0.206 | GABA C receptor rho-3 antagonist | 0.206 0.2 CID_130829 | CID_130829 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |